As food companies stand up digital traceability platforms to meet FSMA 204 requirements—now due by July 2028 after the compliance date extension—a quieter problem is showing up behind the deadline itself.

Most of these platforms are being deployed alongside existing quality management systems (QMS) and audit programs, not integrated into them. The traceability platform tracks lot codes and critical tracking events: harvesting, cooling, initial packing, shipping, receiving, transformation. The QMS tracks a different but overlapping set of facts: supplier documentation, corrective action history, audit findings, certification status. Both systems are supposed to represent the same underlying supplier and product reality. In practice, they often don’t stay in agreement for long.

The result is a familiar set of symptoms: duplicate data entry every time a document or event must be logged, two systems that quietly drift out of sync as staff update one and forget the other, and an audit team that must manually cross-reference a traceability platform against QMS records just to confirm the two are telling the same story before an inspection or a customer audit even begins. None of this is a traceability problem in the technical sense—the traceability platform itself may be working exactly as designed. It’s an integration problem, and it’s one that midsized distributors feel most acutely, because they typically don’t have the dedicated IT resources that large manufacturers can put toward custom system integration.

At Affiliated Foods Inc. (AFI), a wholesale grocery cooperative supplying more than 800 stores across the Southwest, we manage traceability and compliance documentation for more than 1,000 suppliers. Our quality management functions (supplier documentation, corrective actions, and supplier risk tiers) run in ReposiTrak’s compliance management tools, and our FSMA 204 traceability records run on the same platform. Sharing a vendor doesn’t by itself keep two sets of records in agreement, however; that took deliberate configuration.

When we began FSMA 204 implementation, including vendor-exemption scoping and a Technical Assistance Network submission to the FDA to confirm our interpretation of the exemption rules, we made a deliberate decision early in the process: The traceability platform wouldn’t become a second, parallel system that our team had to maintain alongside everything else. Quality records and traceability records would share one supplier identity, and each type of data would have one designated system of record.

That decision shaped almost everything after, and is the core argument of this article: The technical challenge of traceability integration is usually smaller than the organizational challenge of deciding, and enforcing, which system tells the truth.

Why duplicate systems fail quietly

The failure mode here rarely looks dramatic, which is exactly what makes it dangerous. It doesn’t show up as a system outage or a data breach. It looks like a compliance analyst updating a supplier’s document status in the QMS on Tuesday, intending to update the traceability platform with the same information later that week, and then getting pulled into three other priorities before it happens. It looks like an auditor pulling two reports for the same supplier during a routine review and finding a discrepancy—not because anything is actually wrong with the supplier’s compliance status, but because the two systems fell out of sync three weeks earlier, and nobody had a reason to notice until that exact moment.

Multiply that by a supplier base of more than 1,000, and the reconciliation burden compounds quickly. Every discrepancy must be chased down, and every chase-down consumes time that could otherwise go toward actual risk review. Worse, once staff learn through experience which system tends to be more current—usually whichever one they are trained to update first, or whichever one has a friendlier interface—they start treating the other system as a formality. Data still get entered in it, because policy requires it, but it stops being trusted as a source of truth. At that point, the second system isn’t adding a layer of protection. It’s adding a layer of paperwork that everyone quietly works around.

A traceability platform that isn’t trusted internally as accurate is a liability in an audit or an investigation, not an asset—because the moment an outside auditor or FDA investigator asks a question the platform can’t answer confidently, the team has to fall back on the “real” system anyway, and then must explain why two systems exist and which one governs.

We worked through this the same way our team works through any hazard analysis: identify the failure point precisely, design a control that addresses the root cause rather than the symptom, and verify that the control holds under real operating conditions rather than assuming it will. Below are the three integration-failure points we identified, the control we designed for each, and the operational benefit that followed.

Redundant data entry across systems

Compliance staff were entering the same supplier document status—certificates of insurance, HACCP plans, allergen statements, third-party audit certificates, and other routine compliance documents—into both our quality records and our traceability records separately. Every document received meant two data entry events instead of one, and every update to a supplier’s status meant remembering to make the same change twice. For a team managing documentation for more than 1,000 suppliers, that doubling wasn’t a minor inconvenience; it was a structural drag on how much actual review work the team could get through in a day.

Solution: Configure one system as the system of record

Rather than commissioning a custom integration—an expensive option that most midsized distributors can’t easily justify against a compliance deadline, and one that introduces its own maintenance burden once built—we configured ReposiTrak so that one supplier record serves as the single point of document collection and status tracking. Our internal audit workflows were restructured to reference that record directly rather than maintain a parallel, duplicate one. In practice, this meant retraining staff to a single intake process, retiring the old parallel-entry step entirely rather than leaving it as an option, and updating our internal SOPs so that record was named explicitly as the system of record for supplier document status. Document status, once updated in one place, is the status. There’s no second version sitting somewhere else waiting to fall out of agreement with it.

Benefit: Audit trail consistency without manual reconciliation

When an auditor—internal, third-party, or regulatory—needs to verify a supplier’s compliance history, there is exactly one place to look, and it’s the same place the underlying traceability data already live. That eliminates the reconciliation step entirely rather than simply making it faster. It also removes a specific category of audit finding we used to see periodically: discrepancies between systems that took time to investigate and ultimately turned out to be data lag rather than an actual compliance gap. Those false alarms disappeared once there was only one record to check.

Traceability events disconnected from corrective action history

Critical tracking events—shipping, receiving, transformation, along with the key data elements FSMA 204 requires for each—were being logged in the traceability platform with no visibility into whether the supplier associated with that event had an open corrective action, a flagged audit finding, or an elevated risk tier in our quality records. A traceability record could look completely routine on its face while the supplier behind it was, at that same moment, under active review for an unrelated compliance issue. Anyone reviewing traceability data in isolation had no way to know that context existed unless they thought to look it up separately.

Solution: Link supplier risk status to traceability records

We didn’t migrate any corrective-action or risk data. Supplier risk tier and open corrective-action status, already part of the risk-tiered compliance framework our team uses to allocate verification effort, stay where they have always lived: in the compliance management side of ReposiTrak that serves as our QMS. Traceability records stay on the traceability side. What connects them is a shared supplier ID. Every critical tracking event references the same supplier identifier that the CAPA and risk-tier records are keyed to, so an event tied to a flagged or elevated-risk supplier surfaces that status in the same view, with no separate lookup required. The traceability record and the risk record remain two records, joined by one key. Organizations whose QMS runs on a separate platform can start from the same principle, a shared supplier identifier across both systems, before deciding whether any data need to move at all.

Benefit: Risk context at the point of traceability review

A team member reviewing traceability records during a product investigation, a routine audit, or a customer inquiry sees supplier risk status in the same view, instead of needing to cross-reference a second system to understand whether a given supplier warrants closer attention. In a genuine trace-back scenario—where speed matters and every extra lookup step costs real time—that consolidated view is the difference between an investigator immediately understanding a supplier’s risk context and an investigator having to reconstruct it manually while a product safety question is still open.

Vendor exemption status living outside the traceability record

FSMA 204 exemption determinations—which products qualify for exemption under 21 CFR 1.1305(g), and on what regulatory basis (the FDA confirmed to us that these exemptions apply at the product level, not the vendor level)—were initially tracked in internal memos and policy documents kept separate from the traceability platform itself. That separation created a specific risk: A product’s exemption status could exist correctly on paper while not being reflected anywhere the traceability or compliance team worked day by day. A staff member reviewing a product’s traceability requirements had no reason to know an exemption memo existed unless someone told them, or unless they happened to ask the right question at the right time.

Solution: Document exemption status within the platform record

Exemption determinations, along with the supporting documentation and regulatory basis behind each one, are now attached directly to the relevant product and vendor records inside the traceability platform. The exemption basis is visible exactly where a traceability or compliance team member would naturally look for it while doing their job—not filed separately in a policy binder or a shared drive folder where it’s easy to overlook during day-to-day work, and easy to miss entirely during onboarding of new staff.

Benefit: A defensible, centralized compliance record

If the FDA or an auditor asks why a given product isn’t enrolled in full traceability lot-code tracking, the answer—and the documentation supporting it—are attached directly to the product record itself. Nobody has to reconstruct the reasoning from a separate policy file, track down whoever wrote the original memo, or hope the justification was filed somewhere retrievable. Exemption defense lives in the same place the exemption applies.

What this requires from a midsized distributor

None of the changes described above require custom software development, a significant IT budget, or migration of historical quality data, which matters because most midsized distributors have neither the budget nor the internal engineering resources to build a bespoke integration between platforms. What the work required was more organizational than technical:

• A decision made early and made explicitly, about which system is the system of record—and real discipline in enforcing that decision within every team that touches supplier or traceability data, not just the compliance department.

• Configuration work within the existing capabilities of the platforms already in use, rather than defaulting to a new integration project or a new software purchase as the first response to the problem.

• A willingness to retire the habit of maintaining a system “just in case”—the parallel record that exists out of institutional caution long after the primary system has proven itself reliable enough to stand alone.

• Periodic verification that the single system of record holds up under audit conditions, spot-checked the same way any other control would be verified rather than assumed to be working indefinitely.

That last point matters more than it might initially seem. Consolidating onto one system of record isn’t a one-time project with a defined end date. It requires the same ongoing verification discipline as any other food safety control: confirming periodically that the system is being used as intended, that new staff are trained in the current process rather than an outdated one, and that no quiet workaround has crept back in.

The broader point

Traceability compliance and quality management aren’t separate disciplines that happen to overlap. There are two views of the same underlying question: Can you demonstrate, with evidence, that your supply chain is doing what it’s supposed to do? As more distributors stand up digital traceability platforms ahead of the FSMA 204 deadline, and as the industry more broadly moves toward automated and AI-enabled compliance verification, the companies that manage that transition most efficiently will be the ones that give quality and traceability records a single supplier identity and a clear system of record for each type of data—not a parallel system built alongside the QMS to satisfy a separate requirement.

The technology to do this already exists in most traceability platforms currently on the market; almost none of what we did required capability the platform didn’t already have. The harder part, and the part worth getting right early rather than retrofitting later, is the organizational decision to stop maintaining two versions of the truth—and the follow-through to make that decision stick once the initial rollout excitement has worn off, and the systems are simply part of daily operations.